Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Impact of Comorbidities on Early and Late Mortalities After Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Rainer Storb, MD, Brenda M. Sandmaier, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Paul J Martin, MD, Barry Storer, PhD

Blood (2011) 118 (21): 326.

https://doi.org/10.1182/blood.V118.21.326.326

Published: 2011

Journal Articles

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Fabiana Ostronoff, MD, Barry Storer, PhD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J. Martin, MD, Frederick R. Appelbaum, M.D., David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mohamed L. Sorror, MD, MSc

Blood (2011) 118 (21): 665.

https://doi.org/10.1182/blood.V118.21.665.665

Published: 2011

Journal Articles

Impact of the Novel 5-Group Cytogenetic Risk Classification of MDS on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

H. Joachim Deeg, M.D., Bart Lee Scott, MD, Frederick R. Appelbaum, MD, Ted Gooley

Blood (2011) 118 (21): 666.

https://doi.org/10.1182/blood.V118.21.666.666

Published: 2011

Journal Articles

Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

Mouhab Ayas, Jennifer Le-Rademacher, PhD, H. Joachim Deeg, M.D., Robert Peter Gale, MD, PhD, DSc, Stella M. Davies, MBBS, PhD, Rajinder PS Bajwa, MBBS, MD, MRCP, Minoo Battiwalla, MD, MS, Shimon Slavin, MD, Bruce Camitta, MD, Marc B Bierings, MD, PhD, Richard E. Harris, MD, Richard Olsson, MD PhD MMSc, Baldeep Wirk, MD, Biju George, MD, Carmem Bonfim, MD, Wael Saber, MD, MS

Blood (2011) 118 (21): 838.

https://doi.org/10.1182/blood.V118.21.838.838

Published: 2011

Journal Articles

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Blood (2011) 118 (21): 115.

https://doi.org/10.1182/blood.V118.21.115.115

Published: 2011

Journal Articles

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia (SAA): Serious and Unexpected Adverse Events in Pre-Defined Cyclophosphamide (CY) Dose Levels

Jakub Tolar, MD, PhD, H. Joachim Deeg, M.D., Sally Arai, MD, Mitchell Horwitz, MD, Joseph H. Antin, MD, John M. McCarty, MD, Roberta H. Adams, MD, Mary Eapen, MBBS, Marian Ewell, ScD, Eric Leifer, PhD, Iris Gersten, MS, Shelly L Carter, ScD, Mary M. Horowitz, MD, Dennis L Confer, MD, Ryotaro Nakamura, MD, Michael Pulsipher, MD, Nancy L DiFronzo, PhD, Paolo Anderlini, MD

Blood (2011) 118 (21): 3009.

https://doi.org/10.1182/blood.V118.21.3009.3009

Published: 2011

Journal Articles

Impact of Pre-Transplant Comorbidities on the Rate of- and Mortality-Following Acute Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Rainer Storb, MD, Paul J Martin, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Ted A. Gooley, PhD

Blood (2011) 118 (21): 156.

https://doi.org/10.1182/blood.V118.21.156.156

Published: 2011

Journal Articles

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Mohamed L. Sorror, MD, MSc, Fabiana Ostronoff, MD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J Martin, MD, Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M Sandmaier, MD, Barry Storer, PhD

Blood (2011) 118 (21): 145.

https://doi.org/10.1182/blood.V118.21.145.145

Published: 2011

NARROW

Impact of Comorbidities on Early and Late Mortalities After Allogeneic Hematopoietic Cell Transplantation (HCT)

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Impact of the Novel 5-Group Cytogenetic Risk Classification of MDS on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia (SAA): Serious and Unexpected Adverse Events in Pre-Defined Cyclophosphamide (CY) Dose Levels

Impact of Pre-Transplant Comorbidities on the Rate of- and Mortality-Following Acute Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only